{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:23:50Z","timestamp":1791296630820,"version":"4.1.0"},"reference-count":184,"publisher":"Frontiers Media SA","funder":[{"name":"Wellcome Trust grant","award":["093080\/Z\/10\/Z"],"award-info":[{"award-number":["093080\/Z\/10\/Z"]}]},{"DOI":"10.13039\/100005224","name":"National Center for Immunization and Respiratory Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009745","name":"Royal Devon and Exeter NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005292","name":"Instituto de Pesquisa Translacional em Sa\u00fade e Ambiente na Regi\u00e3o Amaz\u00f4nica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00365","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T05:03:01Z","timestamp":1474347781000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":166,"title":["Cancers Related to Immunodeficiencies: Update and Perspectives"],"prefix":"10.3389","volume":"7","author":[{"given":"Esmaeil","family":"Mortaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Tabarsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davod","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Garssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliakbar","family":"Velayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Adcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"issue":"2","key":"B1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1182\/blood.V21.2.197.197","article-title":"Occurrence of leukemia and lymphoma in patients with agammaglobulinemia","volume":"21","author":"Page","year":"1963","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1542\/peds.21.4.526","article-title":"Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection","volume":"21","author":"Boder","year":"1958","journal-title":"Pediatrics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/1097-0142(197107)28:189::AID-CNCR28202801173.0.CO;2-Q","article-title":"Occurrence of malignancy in immunodeficiency diseases","volume":"28","author":"Gatti","year":"1971","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.7326\/0003-4819-77-4-605","article-title":"Immunodeficiency disease and malignancy: various immunologic deficiencies of man and the role of immune processes in the control of malignant disease","volume":"77","author":"Waldmantn","year":"1972","journal-title":"Ann Intern Med"},{"key":"B5","first-page":"267","article-title":"Ataxia-telangiectasia","volume-title":"Handbook of Clinical Neurology","author":"Sedgwick","year":"1972"},{"key":"B6","first-page":"75","article-title":"Immunodeficiency and cancer","volume-title":"Advances in Cancer Research","author":"Kersey","year":"1973"},{"key":"B7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s13312-013-0171-4","article-title":"Diagnostic approach to primary immune deficiency disorders","volume":"50","author":"Madkaikar","year":"2013","journal-title":"Indian Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","article-title":"Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee","volume":"120","author":"Geha","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fimmu.2014.00162","article-title":"Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency","volume":"5","author":"Al-Herz","year":"2014","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","article-title":"Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency","volume":"35","author":"Picard","year":"2015","journal-title":"J Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10875-007-9103-1","article-title":"Population prevalence of diagnosed primary immunodeficiency diseases in the United States","volume":"27","author":"Boyle","year":"2007","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-3476(95)70491-4","article-title":"Cancer in children with primary or secondary immunodeficiencies","volume":"126","author":"Mueller","year":"1996","journal-title":"J Pediatr"},{"issue":"2B","key":"B13","first-page":"1263","article-title":"Development of cancer in patients with primary immunodeficiencies","volume":"28","author":"Salavoura","year":"2008","journal-title":"Anticancer Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10875-011-9523-9","article-title":"Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency","volume":"31","author":"Tabarsi","year":"2011","journal-title":"J Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10875-005-4124-0","article-title":"Primary immune deficiencies presenting in adults: seven years of experience from Iran","volume":"25","author":"Mansouri","year":"2005","journal-title":"J Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1710-1492-7-S1-S11","article-title":"Primary immunodeficiency","volume":"7","author":"McCusker","year":"2011","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1128\/CMR.16.4.597-621.2003","article-title":"Infections in patients with inherited defects in phagocytic function","volume":"16","author":"Andrews","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1128\/CMR.00001-09","article-title":"Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections","volume":"22","author":"Fried","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fimmu.2011.00054","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency","volume":"2","author":"Al-Herz","year":"2011","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-2249.2008.03641.x","article-title":"Clinical immunology review series: an approach to the patient with recurrent infections in childhood","volume":"152","author":"Slatter","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1067\/mai.2003.86","article-title":"Primary immunodeficiency diseases","volume":"111","author":"Bonilla","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1067\/mai.2002.122466","article-title":"Primary immunodeficiency disorders: antibody deficiency","volume":"109","author":"Ballow","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2796.2008.01971.x","article-title":"Revisiting human primary immunodeficiencies","volume":"264","author":"Casanova","year":"2008","journal-title":"J Intern Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fimmu.2014.00197","article-title":"Does the immune system naturally protect against cancer?","volume":"5","author":"Corthay","year":"2014","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(85)91037-2","article-title":"Prospective study of cancer in patients with hypogammaglobulinemia","volume":"1","author":"Kinlen","year":"1985","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/0140-6736(93)90883-I","article-title":"Colorectal cancer in patients with X-linked agammaglobulinemia","volume":"341","author":"van der Meer","year":"1993","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.1073\/pnas.79.19.6008","article-title":"Three distinct stages of B-cell defects in common varied immunodeficiency","volume":"79","author":"Saiki","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","article-title":"Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study","volume":"130","author":"Mellemkjaer","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"B30","first-page":"208","article-title":"Pediatric patients with common variable immunodeficiency: long-term follow-up","volume":"22","author":"Mohammadinejad","year":"2012","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1081-1206(10)61096-4","article-title":"Spectrum of illness in pediatric common variable immunodeficiency","volume":"97","author":"Ogershok","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.autrev.2005.10.002","article-title":"Inflammatory and autoimmune complications of common variable immune deficiency","volume":"5","author":"Knight","year":"2006","journal-title":"Autoimmun Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.autrev.2006.03.010","article-title":"Common variable immune deficiency and autoimmunity","volume":"5","author":"Brandt","year":"2006","journal-title":"Autoimmun Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(08)61199-X","article-title":"Common variable immunodeficiency: a new look at an old disease","volume":"372","author":"Park","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"B37","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/CDLI.12.7.825-832.2005","article-title":"Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency","volume":"12","author":"Aghamohammadi","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF00915550","article-title":"Incidence of cancer in 98 patients with common varied immunodeficiency","volume":"7","author":"Cunningham-Rundles","year":"1987","journal-title":"J Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04384.x","article-title":"Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme","volume":"165","author":"Dhalla","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1182\/blood-2010-03-272351","article-title":"Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?","volume":"116","author":"Vajdic","year":"2010","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0301-0546(09)70254-X","article-title":"Lymphoma as presentation of common variable immunodeficiency","volume":"37","author":"Baron-Ruiz","year":"2009","journal-title":"Allergol Immunopathol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MOH.0b013e328302c7b6","article-title":"Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics","volume":"15","author":"Chua","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/10428190500285285","article-title":"Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency","volume":"47","author":"Aghamohammadi","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"B45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ajh.10050","article-title":"Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency","volume":"69","author":"Cunningham-Rundles","year":"2002","journal-title":"Am J Hematol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","article-title":"Job\u2019s syndrome. Recurrent, \u201ccold\u201d staphylococcal abscesses","volume":"1","author":"Davis","year":"1966","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1542\/peds.49.1.59","article-title":"Extreme hyper immunoglobulinemia E and undue susceptibility to infection","volume":"49","author":"Buckley","year":"1972","journal-title":"Pediatrics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1385\/CRIAI:20:1:139","article-title":"The hyper IgE syndrome","volume":"20","author":"Buckley","year":"2001","journal-title":"Clin Rev Allergy Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1084\/jem.20080321","article-title":"Mutations in STAT3 and IL12RB1 impair the development of human IL-17 producing T cells","volume":"205","author":"Beaucoudrey","year":"2008","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.molimm.2008.07.001","article-title":"Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups","volume":"46","author":"Jiao","year":"2008","journal-title":"Mol Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","article-title":"Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and STAT3 phosphorylation in hyper-IgE syndrome","volume":"122","author":"Renner","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J Exp Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.immuni.2011.09.016","article-title":"A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory","volume":"35","author":"Siegel","year":"2011","journal-title":"Immunity"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1210\/jc.2011-2461","article-title":"Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients","volume":"97","author":"Meloni","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nri2295","article-title":"Th17 cells in development: an updated view of their molecular identity and genetic programming","volume":"8","author":"Dong","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","article-title":"IL-23-IL-17 immune axis: discovery, mechanistic understanding, and clinical testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.it.2010.06.004","article-title":"IL-17 and IL-22: siblings, not twins","volume":"31","author":"Eyerich","year":"2010","journal-title":"Trends Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/pathogens4030606","article-title":"Interleukin 17-mediated host defense against Candida albicans","volume":"4","author":"Sparber","year":"2015","journal-title":"Pathogens"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e1004456","DOI":"10.1371\/journal.ppat.1004456","article-title":"Brothers in arms: Th17 and Treg responses in Candida albicans immunity","volume":"10","author":"Whibley","year":"2014","journal-title":"PLoS Pathog"},{"issue":"4","key":"B63","doi-asserted-by":"publisher","first-page":"e0122807","DOI":"10.1371\/journal.pone.0122807","article-title":"Signaling through IL-17C\/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis","volume":"10","author":"Conti","year":"2015","journal-title":"PLoS One"},{"key":"B64","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 medicates mucosal host defense against Gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/422329","article-title":"Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice","volume":"190","author":"Huang","year":"2004","journal-title":"J Infect Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.4049\/jimmunol.173.5.3482","article-title":"IL-17 markedly up-regulates betadefensin-2 expression in human airway epithelium via JAK and NF-kB signaling pathways","volume":"173","author":"Kao","year":"2004","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.1077002","article-title":"A critical role for IL-21 in regulating immunoglobulin production","volume":"298","author":"Ozaki","year":"2002","journal-title":"Science"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1182\/blood-2008-02-142745","article-title":"STAT3 is required for IL-21 induced secretion of IgE from human naive B cells","volume":"112","author":"Avery","year":"2008","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cellimm.2006.07.011","article-title":"IgE isotype switch and IgE production are enhanced in IL-21-deficient but not IFN-gamma-deficient mice in a Th2-biased response","volume":"241","author":"Shang","year":"2006","journal-title":"Cell Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0022-3476(03)00449-9","article-title":"Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity","volume":"144","author":"Renner","year":"2004","journal-title":"J Pediatr"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jpeds.2012.01.056","article-title":"A patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome","volume":"160","author":"Kilic","year":"2012","journal-title":"J Pediatr"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","article-title":"Combined immunodeficiency associated with DOCK8 mutations","volume":"361","author":"Zhang","year":"2009","journal-title":"N Engl J Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/ni.2305","article-title":"DOCK8 functions as an adaptor that links TLR\u2013MyD88 signaling to B cell activation","volume":"13","author":"Jabara","year":"2012","journal-title":"Nat Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1084\/jem.20110345","article-title":"DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice","volume":"208","author":"Randall","year":"2011","journal-title":"J Exp Med"},{"key":"B76","first-page":"1013","article-title":"Job\u2019s syndrome. Recurrent, \u201ccold\u201d, staphylococcal abscesses","volume":"1","author":"Davi","year":"1966","journal-title":"Lancet"},{"key":"B77","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.iac.2008.01.005","article-title":"The hyper-IgE syndromes","volume":"28","author":"Freeman","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"B78","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1750-1172-6-76","article-title":"The hyperimmunoglobulin E syndrome \u2013 clinical manifestation diversity in primary immune deficiency","volume":"6","author":"Szczawinska-Poplonyk","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3233\/DMA-2010-0739","article-title":"The essential role of DOCK8 in humoral immunity","volume":"29","author":"Randall","year":"2010","journal-title":"Dis Markers"},{"key":"B80","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/ACI.0b013e32833fd718","article-title":"DOCK8 (dedicator of cytokinesis 8) deficiency","volume":"10","author":"Su","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jaci.2014.02.013","article-title":"Autosomal recessive PGM3 mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment","volume":"133","author":"Zhang","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.20091706","article-title":"B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans","volume":"207","author":"Avery","year":"2010","journal-title":"J Exp Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.immuni.2012.03.016","article-title":"Inborn errors of human JAKs and STATs","volume":"36","author":"Casanova","year":"2012","journal-title":"Immunity"},{"key":"B84","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O\u2019Shea","year":"2013","journal-title":"N Engl J Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.4049\/jimmunol.1200744","article-title":"Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma","volume":"189","author":"Forte","year":"2012","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1164\/rccm.201010-1738OC","article-title":"B cells contribute to the antitumor activity of CpG-oligodeoxynucleotide in a mouse model of metastatic lung carcinoma","volume":"183","author":"Sorrentino","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B87","first-page":"775","article-title":"Mucocutaneous candidiasis","volume-title":"Stiehm\u2019s Immunodeficiencies","author":"Mar\u00f3di","year":"2014"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e23435","DOI":"10.4161\/jkst.23435","article-title":"STAT3 and the Hyper-IgE syndrome: clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties","volume":"2","author":"Mogensen","year":"2013","journal-title":"JAKSTAT"},{"key":"B89","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/cid\/cit722","article-title":"Clinical features of Candidiasis in patients with inherited interleukin 12 receptor \u03b21 deficiency","volume":"58","author":"Ouederni","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B90","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/MD.0b013e31828a01f9","article-title":"Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from30 kindreds","volume":"92","author":"Prando","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","article-title":"Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis","volume":"12","author":"Puel","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1002\/eji.201445344","article-title":"Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)","volume":"45","author":"Zheng","year":"2015","journal-title":"Eur J Immunol"},{"key":"B94","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1182\/blood.V124.21.4111.4111","article-title":"STAT1 gain-of-function in patients with chronic mucocutaneous candidiasis can be detected by the excessive phosphorylation of STAT1 in peripheral blood monocytes","volume":"124","author":"Mizoguchi","year":"2014","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.mmcr.2012.02.003","article-title":"Association of esophageal candidiasis and squamous cell carcinoma","volume":"1","author":"Delsing","year":"2012","journal-title":"Med Mycol Case Rep"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/eji.201242605","article-title":"Immunity to infection in IL-17-deficient mice and humans","volume":"42","author":"Cypowyj","year":"2012","journal-title":"Eur J Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jaci.2012.09.011","article-title":"Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species","volume":"130","author":"Mar\u00f3di","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12281-013-0131-4","article-title":"The role of human IL-17 immunity in fungal disease","volume":"7","author":"Mar\u00f3di","year":"2013","journal-title":"Curr Fungal Infect Rep"},{"key":"B100","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.0105-2896.2005.00228.x","article-title":"Hyper-IgE syndromes","volume":"203","author":"Grimbacher","year":"2005","journal-title":"Immunol Rev"},{"key":"B101","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/13693780701616023","article-title":"Chronic mucocutaneous candidiasis and oesophageal cancer","volume":"46","author":"Rosa","year":"2008","journal-title":"Med Mycol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1086\/318796","article-title":"Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis","volume":"68","author":"Goransdotter","year":"2001","journal-title":"Am J Hum Genet"},{"key":"B103","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/jmg.2007.052670","article-title":"Genotype\u2013phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations","volume":"45","author":"Trizzino","year":"2008","journal-title":"J Med Genet"},{"key":"B104","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood.V99.1.61","article-title":"Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members","volume":"99","author":"Kogawa","year":"2002","journal-title":"Blood"},{"key":"B105","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1046\/j.1365-2141.2002.03534.x","article-title":"Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis","volume":"117","author":"Feldmann","year":"2002","journal-title":"Br J Haematol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"63","author":"Janka","year":"2012","journal-title":"Annu Rev Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/nri1983","article-title":"Perforin-mediated target-cell death and immune homeostasis","volume":"6","author":"Voskoboinik","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"B109","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1182\/blood-2011-07-370148","article-title":"Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1182\/blood-2014-05-573105","article-title":"Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis","volume":"124","author":"Zhang","year":"2014","journal-title":"Blood"},{"key":"B111","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bcmd.2014.11.023","article-title":"Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHL) patients in India","volume":"54","author":"Mhatre","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"B112","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","article-title":"Hypercytokinemia in familial hemophagocytic lymphohistiocytosis","volume":"78","author":"Henter","year":"1991","journal-title":"Blood"},{"key":"B113","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood.V73.8.2128.2128","article-title":"Elevated soluble interleukin-2 receptor in childhood hemophagocytic syndromes","volume":"73","author":"Komp","year":"1989","journal-title":"Blood"},{"key":"B114","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/10428199109107916","article-title":"Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndromes","volume":"3","author":"Imashuku","year":"1991","journal-title":"Leuk Lymphoma"},{"key":"B115","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1182\/blood.V89.11.4100","article-title":"Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis","volume":"89","author":"Osugi","year":"1997","journal-title":"Blood"},{"key":"B116","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1182\/blood-2013-06-508267","article-title":"A Mendelian predisposition to B cell lymphoma caused by IL-10R deficiency","volume":"122","author":"Neven","year":"2013","journal-title":"Blood"},{"key":"B117","first-page":"91","article-title":"Lymphoproliferative disorders and other tumors complicating immunodeficiencies","volume":"5","author":"Filipovich","year":"1994","journal-title":"Immunodeficiency"},{"key":"B118","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B119","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF03401731","article-title":"Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, 2B8, 2A1 haplotypes","volume":"4","author":"Schroeder","year":"1998","journal-title":"Mol Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000135694","article-title":"Progression of selective IgA deficiency to common variable immunodeficiency","volume":"147","author":"Aghamohammadi","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"B121","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.158.2.977","article-title":"Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM","volume":"158","author":"Hayward","year":"1997","journal-title":"J Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/cup.12230","article-title":"Primary cutaneous marginal zone lymphoma with sequential development of nodal marginal zone lymphoma in a patient with selective immunoglobulin A deficiency","volume":"40","author":"Wobser","year":"2013","journal-title":"J Cutan Pathol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/00000478-199804000-00017","article-title":"Abdominal T-cell non-Hodgkin\u2019s lymphoma of the gamma\/delta type in a patient with selective immunoglobulin A deficiency","volume":"22","author":"Ott","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"B124","first-page":"748","article-title":"Lymphoproliferative disorders and malignancies related to immunodeficiencies","volume-title":"Principles and Practice of Pediatric Oncology","author":"Gross","year":"2006"},{"key":"B125","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1749-6632.2011.06322.x","article-title":"DNA repair: the link between primary immunodeficiency and cancer","volume":"1246","author":"de Miranda","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"B126","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1182\/blood.V87.2.423.bloodjournal872423","article-title":"Leukemia and lymphoma in ataxia telangiectasia","volume":"87","author":"Taylor","year":"1996","journal-title":"Blood"},{"key":"B127","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/mpo.10251","article-title":"Hodgkin disease in ataxis-telangiectasia patients with poor outcomes","volume":"40","author":"Sandoval","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00019052-199604000-00014","article-title":"Ataxia telangiectasia: cell signaling, cell death and the cell cycle","volume":"9","author":"Heintz","year":"1996","journal-title":"Curr Opin Neurol"},{"key":"B129","first-page":"89","article-title":"Mortality and cancer incidence in 263 patients with ataxia-telangiectasia","volume":"77","author":"Morrell","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"B130","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/pbc.21789","article-title":"Non-Hodgkin lymphoma (NHL) in children with Nijmegen breakage syndrome (NBS)","volume":"52","author":"Dembowska-Baginska","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"B131","author":"Online Mendelian Inheritance in Man (OMIM) database","year":"2009","journal-title":"Johns Hopkins University. Nijmegen Breakage Syndrome"},{"key":"B132","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/jmg.33.2.153","article-title":"Nijmegen breakage syndrome","volume":"33","author":"van der Burgt","year":"1996","journal-title":"J Med Genet"},{"key":"B133","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/nyas.12049","article-title":"Wiskott-Aldrich syndrome: a comprehensive review","volume":"1285","author":"Massaad","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"B134","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3109\/07357908509039813","article-title":"Malignant lymphoma in patients with the Wiskott-Aldrich syndrome","volume":"3","author":"Cotelingam","year":"1985","journal-title":"Cancer Invest"},{"key":"B135","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/ajcp\/110.1.95","article-title":"Follicular large cell lymphoma with immunoblastic features in a child with Wiskott-Aldrich syndrome: an unusual immunodeficiency-related neoplasm not associated with Epstein-Barr virus","volume":"110","author":"Kroft","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cyto.2014.08.003","article-title":"Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review","volume":"71","author":"Singh","year":"2015","journal-title":"Cytokine"},{"key":"B137","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1093\/nar\/gks281","article-title":"Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies","volume":"40","author":"Bresnick","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1128\/IAI.68.8.4720-4724.2000","article-title":"Downregulation of GATA-2 transcription during Pneumocystis carinii infection","volume":"68","author":"Tang","year":"2015","journal-title":"Infect Immun"},{"key":"B139","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1128\/IAI.71.9.4943-4952.2003","article-title":"Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts","volume":"71","author":"Lasbury","year":"2003","journal-title":"Infect Immun"},{"key":"B140","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"B141","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.hoc.2009.01.013","article-title":"Severe congenital neutropenia","volume":"23","author":"Welte","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"B142","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1182\/blood-2006-02-004275","article-title":"Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey","volume":"109","author":"Germeshausen","year":"2007","journal-title":"Blood"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000386035","article-title":"The concept of immunological surveillance","volume":"13","author":"Burnet","year":"1970","journal-title":"Prog Exp Tumor Res"},{"key":"B144","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/nyas.12937","article-title":"Primary immunodeficiencies and the control of Epstein\u2013Barr virus infection","volume":"1356","author":"Umaimainthan","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"B145","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clim.2014.10.003","article-title":"Primary immunodeficiencies in the Netherlands: national patient data demonstrate the increased risk of malignancy","volume":"156","author":"Jonkman-Berk","year":"2015","journal-title":"Clin Immunol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1097\/00006454-198805001-00003","article-title":"Relationship of immunodeficiency to lymphoid malignancy","volume":"7","author":"Kersey","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"B147","first-page":"5465","article-title":"Primary immunodeficiencies: genetic risk factors for lymphoma","volume":"52","author":"Filipovich","year":"1992","journal-title":"Cancer Res"},{"key":"B148","first-page":"106","article-title":"Malignant lymphomas in transplantation patients","volume":"1","author":"Penn","year":"1969","journal-title":"Transplant Proc"},{"key":"B149","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.semcdb.2015.01.015","article-title":"XIAP deficiency syndrome in humans","volume":"39","author":"Latour","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"14524","DOI":"10.1073\/pnas.0907131106","article-title":"XIAP mediates NOD signaling via interaction with RIP2","volume":"106","author":"Krieg","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2012.04.014","article-title":"The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity","volume":"46","author":"Damgaard","year":"2012","journal-title":"Mol Cell"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/emmm.201303090","article-title":"Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling","volume":"5","author":"Damgaard","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/blood-2014-03-564609","article-title":"Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap\u2212\/\u2212 mice","volume":"124","author":"Hsieh","year":"2014","journal-title":"Blood"},{"key":"B154","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-642-56352-2","volume-title":"Immunosurveillance, Immunodeficiency and Lymphoproliferations","author":"Oertel","year":"2002"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J Clin Invest"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"B157","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1126\/science.1063916","article-title":"Regulation of cutaneous malignancy by gamma delta T cells","volume":"294","author":"Girardi","year":"2001","journal-title":"Science"},{"key":"B158","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni1213","article-title":"A critical function for type I interferons in cancer immunoediting","volume":"6","author":"Dunn","year":"2005","journal-title":"Nat Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","article-title":"Demonstration of an interferongamma-dependent tumor surveillance system in immunocompetent mice","volume":"95","author":"Kaplan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B160","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1084\/jem.20020063","article-title":"Suppression of lymphoma and epithelial malignancies effected by interferon gamma","volume":"196","author":"Street","year":"2002","journal-title":"J Exp Med"},{"key":"B161","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1084\/jem.192.5.755","article-title":"Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma","volume":"192","author":"Smyth","year":"2000","journal-title":"J Exp Med"},{"key":"B162","first-page":"529","article-title":"Discussion","volume-title":"Cellular and Humoral Aspects of the Hypersensitive States","author":"Thomas","year":"1959"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors","volume":"2","author":"Calne","year":"1978","journal-title":"Lancet"},{"key":"B164","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(73)93256-X","article-title":"Risk of cancer in renal-transplant recipients","volume":"2","author":"Hoover","year":"1973","journal-title":"Lancet"},{"key":"B165","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1200\/JCO.1987.5.10.1673","article-title":"Lympho proliferative diseases in immuno-compromised hosts: the role of Epstein-Barr virus","volume":"5","author":"List","year":"1987","journal-title":"J Clin Oncol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"B167","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.febslet.2013.10.015","article-title":"Checkpoint blocking antibodies in cancer immunotherapy","volume":"588","author":"Kyi","year":"2014","journal-title":"FEBS Lett"},{"key":"B168","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"B169","doi-asserted-by":"publisher","first-page":"12445","DOI":"10.1073\/pnas.93.22.12445","article-title":"Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium","volume":"93","author":"Groh","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/nature03884","article-title":"The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor","volume":"436","author":"Gasser","year":"2005","journal-title":"Nature"},{"key":"B171","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.1073\/pnas.96.12.6879","article-title":"Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB","volume":"96","author":"Groh","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B172","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1126\/scitranslmed.3007579","article-title":"Immunological visibility: posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway","volume":"6","author":"Vantourout","year":"2014","journal-title":"Sci Transl Med"},{"key":"B173","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.immuni.2008.02.016","article-title":"NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy","volume":"28","author":"Guerra","year":"2008","journal-title":"Immunity"},{"key":"B174","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/jnci\/djt051","article-title":"Genome-wide association study of susceptibility loci for cervical cancer","volume":"105","author":"Chen","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"B175","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/hep.21964","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms","volume":"47","author":"Melum","year":"2008","journal-title":"Hepatology"},{"key":"B176","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1084\/jem.20050381","article-title":"Possible role of human herpes virus 8 in the lymphoproliferative disorders in common variable immunodeficiency","volume":"202","author":"Wheat","year":"2005","journal-title":"J Exp Med"},{"key":"B177","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1365-2249.2006.03209.x","article-title":"The T cell response to persistent herpes virus infections in common variable immunodeficiency","volume":"146","author":"Raeiszadeh","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.humpath.2007.05.020","article-title":"Epstein-Barr virus-associated lymphoproliferative disorders","volume":"38","author":"Rezk","year":"2007","journal-title":"Hum Pathol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"B180","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00043426-198722000-00017","article-title":"The Immunodeficiency Cancer Registry. A research resource","volume":"9","author":"Filipovich","year":"1987","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"B181","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJM198810063191403","article-title":"Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia","volume":"319","author":"A Randomized, Controlled Clinical Trial Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia","year":"1988","journal-title":"N Engl J Med"},{"key":"B182","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood.V73.2.366.366","article-title":"Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors","volume":"73","author":"Griffiths","year":"1989","journal-title":"Blood"},{"key":"B183","first-page":"17","article-title":"Intravenous immune globulin in chronic lymphocytic leukemia","volume":"97","author":"Gamm","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"B184","first-page":"121","article-title":"Prophylaxis against infections with low dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study","volume":"81","author":"Molica","year":"1996","journal-title":"Haematologica"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T01:38:57Z","timestamp":1692495537000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2016.00365\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":184,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00365","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]}}}